ENJAYMO (sutimlimab-jome) is a prescription medicine used to treat hemolysis in adults with Cold Agglutinin Disease (CAD). Specifically, ENJAYMO works by reducing the destruction of red blood cells (hemolysis) in adults with CAD, which helps decrease the need for red blood cell transfusions.
$7,950.00
| Active Ingredient | Sutimlimab-jome |
|---|---|
| Indication | Cold Agglutinin Disease (CAD), Hemolysis management in adults |
| Origin | Germany |
| Packaging | 6 single-dose injection vials |
| Storage Temperature | Refrigerated (2°C to 8°C) |
| Strength | 1100mg/22mL (50mg/mL) |